Scholarlink

Objective <p>Substance-induced psychosis (SIP) is associated with a substantial risk of progression to schizophrenia spectrum disorders (SSD), bipolar disorder (BD), and premature mortality. However, evidence from Asia, particularly South Korea (SK), remains limited.</p> Methods <p>We conducted a retrospective, nationwide, population-based cohort study using the Korean National Health Insurance Claims Database (2003–2012) with follow-up through 2017. Individuals aged 18–60 years with a first episode of SIP (FE-SIP) were identified after excluding those with ICD-10 codes for substance use disorders (SUD; F10-F19) and other neuropsychiatric disorders (F00–F09, F20–F29, F30.x, F31.x, F32.3, or F33.3) during a 1-year washout. Incidence was estimated using national census data. Conversion to first-episode psychosis (FEP-SSD or -BD) was examined using cumulative incidence function and Cox regression. Standardized mortality ratios (SMRs) were calculated against the general population and a SUD reference cohort.</p> Results <p>A total of 2244 individuals with FE-SIP were identified. The average annual incidence proportion was 0.7 per 100,000, peaking in 2005. Over a median follow-up of 9.3 years, 655 individuals (33.2%) converted to FEP, with cumulative conversion rates of 23.3% at 5 years, and 28.8% at 10 years. Younger age, female sex, disability, longer initial hospitalization, and use of other stimulants were significant predictors of conversion. All-cause mortality was markedly elevated (SMR 33.3 vs general population; SMR 1.49 vs SUD cohort), particularly among young men.</p> Conclusions <p>Despite a low incidence of FE-SIP in SK, the risks of conversion to FE-SSD/FE-BD and premature mortality are substantial. Findings underscore the need for early detection, psychoeducation, and integrated care tailored to high-risk individuals, especially within the first two years after diagnosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Predictors of conversion to psychosis and mortality in first-episode substance-induced psychosis: a nationwide register-based study in South Korea

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月6日

查看全文
  • Yan-Hong Piao,
  • Thi-Hung Le,
  • Ling Li,
  • Ariana Setiani,
  • Soyolsaikhan Odkhuu,
  • Woo-Sung Kim,
  • Shahida Nazir,
  • Yong-Suk Jang,
  • Young-Chul Chung

摘要

Objective

Substance-induced psychosis (SIP) is associated with a substantial risk of progression to schizophrenia spectrum disorders (SSD), bipolar disorder (BD), and premature mortality. However, evidence from Asia, particularly South Korea (SK), remains limited.

Methods

We conducted a retrospective, nationwide, population-based cohort study using the Korean National Health Insurance Claims Database (2003–2012) with follow-up through 2017. Individuals aged 18–60 years with a first episode of SIP (FE-SIP) were identified after excluding those with ICD-10 codes for substance use disorders (SUD; F10-F19) and other neuropsychiatric disorders (F00–F09, F20–F29, F30.x, F31.x, F32.3, or F33.3) during a 1-year washout. Incidence was estimated using national census data. Conversion to first-episode psychosis (FEP-SSD or -BD) was examined using cumulative incidence function and Cox regression. Standardized mortality ratios (SMRs) were calculated against the general population and a SUD reference cohort.

Results

A total of 2244 individuals with FE-SIP were identified. The average annual incidence proportion was 0.7 per 100,000, peaking in 2005. Over a median follow-up of 9.3 years, 655 individuals (33.2%) converted to FEP, with cumulative conversion rates of 23.3% at 5 years, and 28.8% at 10 years. Younger age, female sex, disability, longer initial hospitalization, and use of other stimulants were significant predictors of conversion. All-cause mortality was markedly elevated (SMR 33.3 vs general population; SMR 1.49 vs SUD cohort), particularly among young men.

Conclusions

Despite a low incidence of FE-SIP in SK, the risks of conversion to FE-SSD/FE-BD and premature mortality are substantial. Findings underscore the need for early detection, psychoeducation, and integrated care tailored to high-risk individuals, especially within the first two years after diagnosis.